Reply to Letter to Editor: “HER2 positivity in patients with estrogen receptor (ER) positive breast cancer: Is it really prognostic?”

Reply to Letter to Editor: “HER2 positivity in patients with estrogen receptor (ER) positive breast cancer: Is it really prognostic?”

Bibliographic Details
Main Authors:	Shuai Li, Xiaosong Chen
Format:	Article
Language:	English
Published:	Elsevier 2021-02-01
Series:	Breast
Online Access:	http://www.sciencedirect.com/science/article/pii/S0960977620302174

Similar Items

HER2 positivity in patients with estrogen receptor (ER) positive breast cancer: Is it really prognostic?
by: Atul Batra, et al.
Published: (2021-02-01)

HER2 positivity is not associated with adverse prognosis in high-risk estrogen receptor-positive early breast cancer patients treated with chemotherapy and trastuzumab
by: Shuai Li, et al.
Published: (2020-12-01)

Reply to the letter to the editor
by: artiсle Editorial
Published: (2018-10-01)

Reply to Letter to the Editor
by: Kadircan H. Keskinbora, et al.
Published: (2020-12-01)

Reply to the Letter to the editor
by: Sharmila Devi Vadivelu
Published: (2019-01-01)

Reply to the Letter to the Editor
by: Megha Garg
Published: (2021-01-01)

Reply to the letter to editor
by: Parag Sahasrabudhe
Published: (2015-01-01)

Reply to the Letter to the Editor
by: Joon Soon Kang, et al.
Published: (2020-04-01)

Reply to the letter to editor
by: Parag Sahasrabudhe
Published: (2015-01-01)

Reply to the Letter to the Editor
by: Ulunay Kanatlı, et al.
Published: (2020-05-01)

Reply to the letter to the Editor
by: Fabricio Tavares Mendonça, et al.

Reply to Letter to the Editor
by: Richard J. Glassock, et al.

Reply to letter to the editor
by: Sweta Hasmukh Rambhia, MBBS, DVD, et al.
Published: (2021-06-01)

Reply to the letter to the Editor
by: Sara Bignulin, et al.
Published: (2016-11-01)

Reply Letter to the Editor
by: Po-Hua Huang
Published: (2021-06-01)

Reply to letter to the Editor
by: Cédric Lenoir, et al.
Published: (2019-01-01)

Reply to Letter to the Editor
by: Paul A. Muller, et al.
Published: (2013-01-01)

Reply to Letter to the Editor
by: Paul B. Fitzgerald, MBBS, MPM, PhD, FRANZCP, et al.
Published: (2013-05-01)

Letter to the editor: Reply
by: Jung-Woo Shim, et al.
Published: (2021-03-01)

Reply to letter to the editor
by: Mason Stilman, et al.
Published: (2020-05-01)

Reply to letter to the editor
by: Stephen Bornheim, et al.
Published: (2020-07-01)

Prognostic Impact of Low Estrogen and Progesterone Positivity in Luminal B (HER2 Negative) Breast Cancer
by: Jasmina Rajc, et al.
Published: (2018-01-01)

Are letters to the editor really useful?
by: Sergio Alexis Dominguez-Lara
Published: (2016-08-01)

Direct estrogen receptor (ER) / HER family crosstalk mediating sensitivity to lumretuzumab and pertuzumab in ER+ breast cancer.
by: Denis Collins, et al.
Published: (2017-01-01)

G2M Cell Cycle Pathway Score as a Prognostic Biomarker of Metastasis in Estrogen Receptor (ER)-Positive Breast Cancer
by: Masanori Oshi, et al.
Published: (2020-04-01)

Distribution and Prognostic Significance of Estrogen Receptor α (ERα), Estrogen Receptor β (ERβ), and Human Epidermal Growth Factor Receptor 2 (HER-2) in Thyroid Carcinoma
by: Anjali Mishra, et al.
Published: (2020-01-01)

Altona Prognostic Index: A New Prognostic Index for ER-Positive and Her2-Negative Breast Cancer of No Special Type
by: Anne-Sophie Wegscheider, et al.
Published: (2021-07-01)

Estrogens Correlate with PELP1 Expression in ER Positive Breast Cancer.
by: Marianne Hauglid Flågeng, et al.
Published: (2015-01-01)

Letter to Editor The Authors’ Reply
by: Mohammad Farajzadeh, et al.
Published: (2017-10-01)

ER-α36-mediated rapid estrogen signaling positively regulates ER-positive breast cancer stem/progenitor cells.
by: Hao Deng, et al.
Published: (2014-01-01)

Estrogen receptor alpha (ERα) mRNA copy numbers in immunohistochemically ERα-positive-, and negative breast cancer tissues
by: Yue Qingqi, et al.
Published: (2007-03-01)

A Novel Prognostic Scoring System Integrating Gene Expressions and Clinicopathological Characteristics to Predict Very Early Relapse in Node-Negative Estrogen Receptor-Positive/HER2-Negative Breast Cancer
by: Caijin Lin, et al.
Published: (2020-09-01)

Prognostic effect of hormone receptor status in early HER2 positive breast cancer patients
by: Henry L. Gómez, et al.
Published: (2010-07-01)

Prognostic impact of HER2-low expression in hormone receptor positive early breast cancer
by: Raz Mutai, et al.
Published: (2021-12-01)

The prognostic effects of somatic mutations in ER-positive breast cancer
by: Obi L. Griffith, et al.
Published: (2018-09-01)

Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis
by: Jun-Rong Wu, et al.
Published: (2020-01-01)

Reply to the letter to the editor by R. Papke
by: Exner, Martin, et al.
Published: (2021-06-01)

Mouse models of estrogen receptor-positive breast cancer
by: Shakur Mohibi, et al.
Published: (2011-01-01)

Clinical Overestimation of HER2 Positivity in Early Estrogen and Progesterone Receptor–Positive Breast Cancer and the Value of Molecular Subtyping Using BluePrint
by: Ettienne J. Myburgh, et al.
Published: (2017-08-01)

The Central Contributions of Breast Cancer Stem Cells in Developing Resistance to Endocrine Therapy in Estrogen Receptor (ER)-Positive Breast Cancer
by: David Rodriguez, et al.
Published: (2019-07-01)

Cannot write session to /tmp/vufind_sessions/sess_8h47eq518f67ho21es2fd6rjnb